MLTX - MoonLake Immunotherapies - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

2.281B

Cash

547.1M

Avg Qtr Burn

-12.18M

Short % of Float

33.63%

Insider Ownership

15.27%

Institutional Own.

97.37%

Qtr Updated

03/31/24

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Sonelokimab Details Hidradenitis suppurativa	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Sonelokimab Details Psoriatic arthritis	Phase 3 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.